No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Brentuximab Vedotin is a safe and effective treatment in patients with Mycosis Fungoides and Sezary Syndrome

byKathleen Lau

June 24, 2021

in StudyGraphics

Proton therapy associated with reduced toxicity and equivalent survival outcomes vs radiation therapy amongst patients with nonmetastatic nasopharygneal carcinoma

RelatedReports

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

April 30, 2026

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Chronic Disease

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

April 15, 2026

Eczema more prevalent among older adults than previously thought

Cardiology

Atopic dermatitis activity is not associated with cardiovascular risk

April 2, 2026

Radiation plus hormone therapy may improve prostate cancer survival

Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026

Conventional cardiovascular risk assessments may overestimate risk in populations with widespread diabetes screening guidelines

CHADS-VASc score may help predict outcomes in heart failure

Burden of ischemic stroke increased in patients with congenital heart disease

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Bridging with low molecular weight heparin may not be beneficial for patients with atrial fibrillation or mechanical heart valves

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports